Sanofi: Blackrock now holds over 5% of voting rights.
(CercleFinance.com) - BlackRock Inc.
, acting on behalf of clients and funds under its management, has informed the AMF that it has increased its stake to above the 5% threshold of Sanofi's voting rights on 17 August and now holds, on behalf of its clients and funds, 5.64% of capital and 5.06% of the voting rights of the French pharmaceutical company.
The crossing of this threshold results from the purchase of Sanofi shares on the market and an increase in the number of shares held as collateral.
Copyright (c) 2017 CercleFinance.com. All rights reserved.
, acting on behalf of clients and funds under its management, has informed the AMF that it has increased its stake to above the 5% threshold of Sanofi's voting rights on 17 August and now holds, on behalf of its clients and funds, 5.64% of capital and 5.06% of the voting rights of the French pharmaceutical company.
The crossing of this threshold results from the purchase of Sanofi shares on the market and an increase in the number of shares held as collateral.
Copyright (c) 2017 CercleFinance.com. All rights reserved.